default author photo

Xiang Yan

Government of the People's Republic of China - Department of Oncology

China

SCHOLARLY PAPERS

3

DOWNLOADS

170

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

Dynamics of Serum Tumor Markers Predict Benefit from Immune Checkpoint Inhibitors in Chinese Patients with Advanced Non-Small Cell Lung Cancer

Number of pages: 34 Posted: 19 Dec 2019
Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, Government of the People's Republic of China - First Medical Center, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, BeiGene (Shanghai) Co., Ltd, BeiGene (Shanghai) Co., Ltd, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology and Government of the People's Republic of China - Department of Oncology
Downloads 70 (875,328)

Abstract:

Loading...

Non-small cell lung cancer, serum tumor markers, Chinese patients, immune checkpoint inhibitors, efficacy

2.

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts the Outcomes of Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Immune Checkpoint Inhibitors (ICIs)

Number of pages: 30 Posted: 03 Dec 2019
Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, 3D Medicines, Inc., University of Texas at Houston - Department of Genomic Medicine, Government of the People's Republic of China - Department of Oncology and Government of the People's Republic of China - Department of Oncology
Downloads 50 (1,063,489)

Abstract:

Loading...

Non-small cell lung cancer; neutrophil-to-lymphocyte ratio; peripheral blood biomarker; immunotherapy

3.

PTK2 Promotes Hepatocellular Carcinoma Cancer Stem Cell Traits and Tumorigenicity by Activating Wnt/β-Catenin Signaling

Number of pages: 42 Posted: 27 Sep 2018
Government of the People's Republic of China - Department of Oncology, Nankai University, Government of the People's Republic of China - Chinese PLA General Hospital, Beijing University of Chinese Medicine - Dongzhimen Hospital, Nankai University, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Beijing University of Chinese Medicine - Dongzhimen Hospital, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology and Beijing Institute of Biotechnology - Department of Medical Molecular Biology
Downloads 50 (1,063,489)
Citation 1

Abstract:

Loading...

FAK, Liver Cancer, CSCs, Sorafenib Resistance, Methylation